MicroRNA (miRNA) therapeutics represent the new frontier in the fight against human disease. The importance of miRNAs in cancer development, and their potential to reverse it, are only beginning to be unraveled. 

Deficiencies in microRNA levels lead to overexpression of proteins that promote cancer aggressiveness, including traits such as tumor cell growth, spread, and resistance to chemotherapy. 

Using the latest in nanotechnology and synthetic biology we can reintroduce these missing microRNAs into tumor cells, stopping and reversing the spread of cancer. 

Our technology has been demonstrated, in peer-reviewed publications, to work both alone and in combination with existing cancer-fighting agents to reduce tumor burden and metastasis, improving the effectivity of currently used treatments.